11.07.2015 Views

Clinician's Pocket Drug Reference 2008

Clinician's Pocket Drug Reference 2008

Clinician's Pocket Drug Reference 2008

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Clozapine 67Clopidogrel (Plavix) Uses: *Reduce atherosclerotic events*, administerASAP in ECC setting w/ high risk ST depression or T wave inversion Action: ↓Plt aggregation Dose: 75 mg/d; 300-600 mg PO × 1 dose can be used to load pts;300 mg PO, then 75 mg Daily 1–9 mo (ECC 2005) Caution: [B, ?] Active bleeding;risk of bleeding from trauma & other; TTP; liver Dz Contra: Coagulation disorders,active/or intracranial bleeding; CABG planned w/in 5–7 days Disp: Tabs75 mg SE: ↑ bleeding time, GI intolerance, HA, dizziness, rash, thrombocytopenia,↓ WBC Notes: Plt aggregation to baseline ≈ 5 days after D/C, plt transfusionto reverse acutelyClorazepate (Tranxene) [C-IV] Uses: *Acute anxiety disorders, acuteEtOH withdrawal Sxs, adjunctive therapy in partial Szs* Action: Benzodiazepine;antianxiety agent Dose: Adults. 15–60 mg/d PO single or ÷ doses. Elderly & debilitatedpts: Initial 7.5–15 mg/d in ÷ doses. EtOH withdrawal: Day 1: Initial 30 mg;then 30–60 mg ÷ doses; Day 2: 45–90 mg ÷ doses; Day 3: 22.5–45 mg ÷ doses; Day4: 15–30 mg ÷ doses. Peds. 3.75–7.5 mg/dose bid to 60 mg/d max ÷ bid-tid Caution:[D, ?/–] Elderly; Hx depression Contra: NAG; Not OK

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!